Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H25Cl2N3O2 |
| Molecular Weight | 434.359 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClCCN(CCCl)CCOC(=O)CCNC1=C2C=CC=CC2=NC3=CC=CC=C13
InChI
InChIKey=BDLWRIAFNYVGTC-UHFFFAOYSA-N
InChI=1S/C22H25Cl2N3O2/c23-10-13-27(14-11-24)15-16-29-21(28)9-12-25-22-17-5-1-3-7-19(17)26-20-8-4-2-6-18(20)22/h1-8H,9-16H2,(H,25,26)
Amustaline (S-303) is a quinacrine mustard compound with potential antineoplastic activity. Amustaline binds to, intercalates and crosslinks DNA and RNA. This agent is mainly used for ex vivo purposes, specifically for the inactivation of pathogens such as viruses, protozoa and bacteria in red blood cells (RBCs). When S-303 is added to red blood cells, the compound rapidly passes through membranes, including those of cells and viral envelopes, due to its amphipathic character, and intercalates into helical regions of the nucleic acids of pathogens and white blood cells. TERCEPTTMBlood System usingamustaline (S-303) and glutathione (GSH) was able to inactivate high levels of DENV and ZIKV in RBCs. S-303 system has been shown to effectively inactivate a broad spectrum of pathogens, while maintaining RBC quality.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery. | 2018-04 |
|
| Amustaline (S-303) treatment inactivates high levels of Chikungunya virus in red-blood-cell components. | 2018-04 |
|
| Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione. | 2017-12 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19995680
Curator's Comment: A series of experiments were performed in whole blood (WB) to measure the level of viral and bacterial inactivation.
0.2mM S-303 and 2mM glutathione (GSH) inactivated >6.5 logs of HIV, >5.7 logs of Bluetongue virus, >7.0 logs of Yersinia enterocolitica, 4.2 logs of Serratia marcescens, and 7.5 logs of Staphylococcus epidermidis. A series of studies in RBC showed that 0.2mM S-303 and 20mM GSH inactivated approximately 5 logs or greater of Y. enterocolitica, E. coli, S. marcescens, S. aureus, HIV, bovine viral diarrhoea virus, bluetongue virus and human adenovirus 5.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1590
Created by
admin on Mon Mar 31 18:17:41 GMT 2025 , Edited by admin on Mon Mar 31 18:17:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
25571657UW
Created by
admin on Mon Mar 31 18:17:41 GMT 2025 , Edited by admin on Mon Mar 31 18:17:41 GMT 2025
|
PRIMARY | |||
|
220180-88-1
Created by
admin on Mon Mar 31 18:17:41 GMT 2025 , Edited by admin on Mon Mar 31 18:17:41 GMT 2025
|
PRIMARY | |||
|
C75926
Created by
admin on Mon Mar 31 18:17:41 GMT 2025 , Edited by admin on Mon Mar 31 18:17:41 GMT 2025
|
PRIMARY | |||
|
DTXSID20176473
Created by
admin on Mon Mar 31 18:17:41 GMT 2025 , Edited by admin on Mon Mar 31 18:17:41 GMT 2025
|
PRIMARY | |||
|
6433104
Created by
admin on Mon Mar 31 18:17:41 GMT 2025 , Edited by admin on Mon Mar 31 18:17:41 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)